Emérito Amaro-Carambot

857 total citations
22 papers, 634 citations indexed

About

Emérito Amaro-Carambot is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Emérito Amaro-Carambot has authored 22 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 20 papers in Infectious Diseases and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Emérito Amaro-Carambot's work include Respiratory viral infections research (18 papers), Virology and Viral Diseases (15 papers) and Viral Infections and Vectors (14 papers). Emérito Amaro-Carambot is often cited by papers focused on Respiratory viral infections research (18 papers), Virology and Viral Diseases (15 papers) and Viral Infections and Vectors (14 papers). Emérito Amaro-Carambot collaborates with scholars based in United States, Australia and Puerto Rico. Emérito Amaro-Carambot's co-authors include Peter L. Collins, Sonja R. Surman, Mario H. Skiadopoulos, Brian R. Murphy, Ursula J. Buchholz, Stéphane Biacchesi, Emmalene J. Bartlett, Marisa St. Claire, Nicolaas Schaap and William R. Elkins and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Virology.

In The Last Decade

Emérito Amaro-Carambot

22 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emérito Amaro-Carambot United States	15	554	445	92	62	58	22	634
Sek Mardy Cambodia	14	666 1.2×	346 0.8×	40 0.4×	73 1.2×	36 0.6×	22	745
Kevin C. Yim United States	13	522 0.9×	335 0.8×	173 1.9×	118 1.9×	51 0.9×	24	685
Debra Hauer United States	14	341 0.6×	314 0.7×	209 2.3×	59 1.0×	25 0.4×	18	627
Maria Torsellini Italy	17	545 1.0×	274 0.6×	53 0.6×	32 0.5×	54 0.9×	24	649
Kevin W. Graepel United States	7	576 1.0×	481 1.1×	56 0.6×	147 2.4×	54 0.9×	8	809
Aizhong Hu Sweden	12	432 0.8×	153 0.3×	81 0.9×	65 1.0×	31 0.5×	17	484
Olga Cano Spain	9	409 0.7×	308 0.7×	44 0.5×	72 1.2×	43 0.7×	18	507
Sandra Fuentes United States	9	316 0.6×	205 0.5×	49 0.5×	65 1.0×	29 0.5×	19	413
John Brunstein Canada	10	222 0.4×	251 0.6×	42 0.5×	60 1.0×	19 0.3×	26	448
Allan Paras United Kingdom	5	436 0.8×	222 0.5×	246 2.7×	168 2.7×	36 0.6×	5	683

Countries citing papers authored by Emérito Amaro-Carambot

Since Specialization

Citations

This map shows the geographic impact of Emérito Amaro-Carambot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emérito Amaro-Carambot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emérito Amaro-Carambot more than expected).

Fields of papers citing papers by Emérito Amaro-Carambot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emérito Amaro-Carambot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emérito Amaro-Carambot. The network helps show where Emérito Amaro-Carambot may publish in the future.

Co-authorship network of co-authors of Emérito Amaro-Carambot

This figure shows the co-authorship network connecting the top 25 collaborators of Emérito Amaro-Carambot. A scholar is included among the top collaborators of Emérito Amaro-Carambot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emérito Amaro-Carambot. Emérito Amaro-Carambot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Amaro-Carambot, Emérito, et al.. (2024). Simultaneous quantitation of neutralizing antibodies against all four dengue virus serotypes using optimized reporter virus particles. Journal of Virology. 98(7). e0068124–e0068124. 2 indexed citations

Chen, Rita E., Brittany Smith, John M. Errico, et al.. (2021). Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity. Cell Host & Microbe. 29(11). 1634–1648.e5. 8 indexed citations

Liu, Xueqiao, Bo Liang, Xiang Liu, et al.. (2020). Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates. PLoS ONE. 15(2). e0228572–e0228572. 17 indexed citations

Vinton, Carol L., Kimberly A. Dowd, Shelly J. Robertson, et al.. (2019). Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in Delayed Zika Virus Clearance. mBio. 10(6). 6 indexed citations

Tsetsarkin, Konstantin A., Olga A. Maximova, Guangping Liu, et al.. (2018). Routes of Zika virus dissemination in the testis and epididymis of immunodeficient mice. Nature Communications. 9(1). 5350–5350. 28 indexed citations

Liang, Bo, Joan O. Ngwuta, Richard Herbert, et al.. (2016). Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector. Journal of Virology. 90(21). 10022–10038. 31 indexed citations

Liang, Bo, Sonja R. Surman, Emérito Amaro-Carambot, et al.. (2015). Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate. Journal of Virology. 89(18). 9499–9510. 57 indexed citations

Surman, Sonja R., et al.. (2015). The Aberrant Gene-End Transcription Signal of the Matrix M Gene of Human Parainfluenza Virus Type 3 Downregulates Fusion F Protein Expression and the F-Specific Antibody Response In Vivo. Journal of Virology. 89(6). 3318–3331. 3 indexed citations

Liang, Bo, Shirin Munir, Emérito Amaro-Carambot, et al.. (2014). Chimeric Bovine/Human Parainfluenza Virus Type 3 Expressing Respiratory Syncytial Virus (RSV) F Glycoprotein: Effect of Insert Position on Expression, Replication, Immunogenicity, Stability, and Protection against RSV Infection. Journal of Virology. 88(8). 4237–4250. 26 indexed citations

10.

Boonyaratanakornkit, Jim, et al.. (2012). The C Proteins of Human Parainfluenza Virus Type 1 Block IFN Signaling by Binding and Retaining Stat1 in Perinuclear Aggregates at the Late Endosome. PLoS ONE. 7(2). e28382–e28382. 21 indexed citations

11.

Schaap, Nicolaas, Christopher R. D’Angelo, Emérito Amaro-Carambot, et al.. (2010). Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates. Virology. 406(1). 65–79. 8 indexed citations

12.

Schaap, Nicolaas, Christopher R. D’Angelo, Margaret A. Scull, et al.. (2009). Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates. Virology. 397(2). 285–298. 16 indexed citations

13.

Boonyaratanakornkit, Jim, Emmalene J. Bartlett, Emérito Amaro-Carambot, et al.. (2008). The C Proteins of Human Parainfluenza Virus Type 1 (HPIV1) Control the Transcription of a Broad Array of Cellular Genes That Would Otherwise Respond to HPIV1 Infection. Journal of Virology. 83(4). 1892–1910. 14 indexed citations

14.

Nolan, Sheila M., Mario H. Skiadopoulos, Konrad C. Bradley, et al.. (2007). Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3′ genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates. Vaccine. 25(34). 6409–6422. 14 indexed citations

15.

Cleve, Wil Van, Emérito Amaro-Carambot, Sonja R. Surman, et al.. (2006). Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. Virology. 352(1). 61–73. 34 indexed citations

16.

Nolan, Sheila M., Sonja R. Surman, Emérito Amaro-Carambot, et al.. (2005). Live-attenuated intranasal parainfluenza virus type 2 vaccine candidates developed by reverse genetics containing L polymerase protein mutations imported from heterologous paramyxoviruses. Vaccine. 23(39). 4765–4774. 17 indexed citations

17.

Bartlett, Emmalene J., Emérito Amaro-Carambot, Sonja R. Surman, et al.. (2005). Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys. Vaccine. 23(38). 4631–4646. 34 indexed citations

18.

Bartlett, Emmalene J., Emérito Amaro-Carambot, Sonja R. Surman, et al.. (2005). Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates. Vaccine. 24(14). 2674–2684. 23 indexed citations

19.

Skiadopoulos, Mario H., Stéphane Biacchesi, Ursula J. Buchholz, et al.. (2005). Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology. 345(2). 492–501. 104 indexed citations

20.

Skiadopoulos, Mario H., Stéphane Biacchesi, Ursula J. Buchholz, et al.. (2004). The Two Major Human Metapneumovirus Genetic Lineages Are Highly Related Antigenically, and the Fusion (F) Protein Is a Major Contributor to This Antigenic Relatedness. Journal of Virology. 78(13). 6927–6937. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact